Related Experiment Video

Updated: Aug 16, 2026

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
12:00

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

Phenolic compounds from blueberries can inhibit colon cancer cell proliferation and induce apoptosis

Weiguang Yi1, Joan Fischer, Gerard Krewer

  • 1Department of Food Science and Technology, The University of Georgia, Athens, Georgia 30602-7610, USA.

Journal of Agricultural and Food Chemistry
|September 1, 2005
PubMed

Insights

Blueberry phenolic compounds, especially anthocyanins, show significant antiproliferation and apoptosis-inducing effects on colon cancer cells. These findings suggest that regular blueberry consumption may help reduce the risk of colon cancer.

Area of Science:

  • Nutritional Science
  • Cancer Biology
  • Pharmacology

Background:

  • Diets rich in phenolic compounds are linked to reduced chronic disease risk, including cancer.
  • Rabbiteye blueberries are a source of various phenolic compounds.
  • Colon cancer remains a significant global health concern.

Purpose of the Study:

  • To evaluate the bioactivities of phenolic compounds from rabbiteye blueberries.
  • To assess their potential to inhibit colon cancer cell proliferation and induce apoptosis.
  • To identify which phenolic fractions exhibit the most potent anti-cancer effects.

Main Methods:

  • Phenolic compounds were extracted from three blueberry cultivars (Briteblue, Tifblue, Powderblue).
  • Extracts were fractionated into phenolic acids, tannins, flavonols, and anthocyanins.
  • Antiproliferation and apoptosis induction effects were tested on HT-29 and Caco-2 colon cancer cell lines.

Main Results:

  • Flavonol and tannin fractions inhibited cell proliferation by 50% at 70-100 microg/mL.
  • Phenolic acid fractions showed lower activity, with 50% inhibition around 1000 microg/mL.
  • Anthocyanin fractions demonstrated the strongest antiproliferation effect (>50% inhibition at 15-50 microg/mL) and induced 2-7 times more DNA fragmentation, indicating apoptosis.

Conclusions:

  • Blueberry anthocyanins possess significant antiproliferative and apoptosis-inducing properties against colon cancer cells.
  • The effective concentrations are comparable to plasma levels observed in vivo.
  • These results support the potential of blueberry consumption as a dietary strategy to reduce colon cancer risk.

More Related Videos

Colletotrichum fioriniae Development in Water and Chloroform-based Blueberry and Cranberry Floral Extracts12:32

Colletotrichum fioriniae Development in Water and Chloroform-based Blueberry and Cranberry Floral Extracts

Published on: April 12, 2019

Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells06:07

Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells

Published on: June 13, 2020

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...